Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CureVac N.V (CVAC) Gross Profit: 2019-2025

Historic Gross Profit for CureVac N.V (CVAC) over the last 4 years, with Jun 2025 value amounting to -$1.1 million.

  • CureVac N.V's Gross Profit rose 96.13% to -$1.1 million in Q2 2025 from the same period last year, while for Jun 2025 it was $531.2 million, marking a year-over-year increase of 620.77%. This contributed to the annual value of $458.8 million for FY2024, which is 703.93% up from last year.
  • Latest data reveals that CureVac N.V reported Gross Profit of -$1.1 million as of Q2 2025, which was down 5,881.18% from $18,934 recorded in Q1 2025.
  • In the past 5 years, CureVac N.V's Gross Profit ranged from a high of $518.3 million in Q3 2024 and a low of -$101.1 million during Q3 2021.
  • Over the past 3 years, CureVac N.V's median Gross Profit value was -$11.5 million (recorded in 2023), while the average stood at $39.5 million.
  • In the last 5 years, CureVac N.V's Gross Profit slumped by 2,713,918.24% in 2021 and then skyrocketed by 6,206.00% in 2024.
  • Quarterly analysis of 5 years shows CureVac N.V's Gross Profit stood at -$33.0 million in 2021, then tumbled by 111.38% to -$69.7 million in 2022, then skyrocketed by 52.14% to -$33.3 million in 2023, then surged by 141.70% to $13.9 million in 2024, then skyrocketed by 96.13% to -$1.1 million in 2025.
  • Its last three reported values are -$1.1 million in Q2 2025, $18,934 for Q1 2025, and $13.9 million during Q4 2024.